ADGM NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Adagio Medical Holdings, Inc Common Stock · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 0.38 USD
-21.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -59.0% below the Trend Line and sits at 0.7% of its 52-week range. The latest completed week returned -21.5%, after a -40.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: earnings are due in 10d.

Setup score 22 out of 100
Latest Close 0.38 USD 31 Jul 2026
1W Return -21.5% latest completed week
4W Return -40.6% short-term follow-through
12W Return -61.2% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -21.5% Latest completed week; four-week move -40.6%. Indicator stack 16/31 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 63 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -59.0% below the Trend Line and sits at 0.7% of its 52-week range. The latest completed week returned -21.5%, after a -40.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0012-week average 0.15

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -40.6% over four weeks, -61.2% over 12 weeks, and -70.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-21.5%
4W-40.6%
12W-61.2%
26W-62.2%
52W-70.0%
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.00Latest activity-pressure read.
Pressure change-6.9%Four-week change in activity pressure.
Leadership-68.67Latest relative-leadership reading.
RS change-29.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 58% Model confidence 55%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength75/100Blend of value, momentum, and quality. Underlying universe rank 26; rank 1 is best.
Value62/100Relative valuation strength. Underlying universe rank 39; rank 1 is best.
Quality60/100Profitability and accounting quality. Underlying universe rank 41; rank 1 is best.
Momentum62/100Medium-term price momentum. Underlying universe rank 39; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-66.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-94.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 63 relevant articles.

7 positive · 48 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-85.3%Distance below the 52-week high.
13-week volatility6.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2616 weeks finished lower.
Best week+21.1%Week of 17 Apr.
Worst week-31.8%Week of 1 May.
Latest week-21.5%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains5
Flat weeks1
Modest losses6
Sharp losses10
Recent vol6.2%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -9.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 1/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.00; No reversal markers Factors64/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 63 relevant articles.

Adagio Medical Holdings Inc (ADGM) Institutional Confidence Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.38 USD-21.5%0.92 USD1.62 USD-1.00-68.67517.6KOff
24 Jul 20260.48 USD-9.1%0.95 USD1.63 USD-1.01-60.60478.1KOff
17 Jul 20260.53 USD-7.0%0.97 USD1.64 USD-1.00-58.42187.6KOff
10 Jul 20260.57 USD-10.5%0.98 USD1.65 USD-0.98-57.91405.1KOff
3 Jul 20260.64 USD-1.4%1.00 USD1.66 USD-0.94-53.22247.4KOff
26 Jun 20260.65 USD-5.0%1.01 USD1.67 USD-0.89-53.05388.4KOff
19 Jun 20260.68 USD-8.7%1.01 USD1.68 USD-0.86-53.44176.4KOff
12 Jun 20260.74 USD2.8%1.01 USD1.69 USD-0.74-48.22402.9KOff
5 Jun 20260.72 USD0.1%1.02 USD1.70 USD-0.65-48.96659.0KOff
29 May 20260.72 USD-13.9%1.02 USD1.71 USD-0.47-51.96525.6KOff
22 May 20260.84 USD-2.3%1.04 USD1.72 USD-0.20-43.221.2MOff
15 May 20260.86 USD-11.8%1.05 USD1.73 USD0.32-41.85255.6KOn
8 May 20260.97 USD-5.3%1.07 USD1.74 USD0.83-34.95241.3KOn
1 May 20261.03 USD-31.8%1.10 USD1.75 USD1.18-28.561.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.